* Annexon Inc ANNX.OQ reported a quarterly adjusted loss
of 21
cents per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -52
cents. The mean expectation of eight analysts for the quarter
was for a loss of 34 cents per share. Wall Street expected
results to range from -40 cents to -26 cents per share.
* Reported revenue was zero; analysts expected zero.
* Annexon Inc's reported EPS for the quarter was a loss
of 21
cents.
* The company reported a quarterly loss of $25.18 million.
* Annexon Inc shares had fallen by 33.8% this quarter and
gained 4.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 25% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Annexon Inc is
$12.00
This summary was machine generated from LSEG data May 13 at
02:13 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.34 -0.21 Beat
Dec. 31 2023 -0.44 -0.36 Beat
Sep. 30 2023 -0.50 -0.43 Beat
Jun. 30 2023 -0.54 -0.47 Beat